Home › Funds › COOKE & BIELER LP › LH
COOKE & BIELER LP position in LH
LABCORP HOLDINGS INC · Health Care
COOKE & BIELER LP reported holding 490,641 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$151.2M, representing 2.38% of its reported portfolio and ranking #8 among its reported holdings. COOKE & BIELER LP has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How COOKE & BIELER LP's LH position evolved
COOKE & BIELER LP first disclosed a stake in LH in Q3 2023 at 689,716 shares (US$138.7M). The position peaked in Q3 2025 at 754,449 shares, worth US$216.6M. Across 13 filings, COOKE & BIELER LP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 490,641 shares valued at US$151.2M — a reduction of -178,537 shares quarter over quarter.. Notable position changes include a 27% increase in Q2 2024 (shares rose 10% over the following quarter), a 27% trim in Q3 2026 (shares rose 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 689.72K | $138.67M | New |
| Q4 2023 | 672.35K | $152.82M | Reduce |
| Q1 2024 | 732.13K | $159.94M | Add |
| Q2 2024 | 928.25K | $188.91M | Add |
| Q3 2024 | 942.10K | $210.54M | Add |
| Q4 2024 | 848.26K | $194.52M | Reduce |
| Q1 2025 | 833.22K | $193.92M | Reduce |
| Q2 2025 | 817.93K | $214.72M | Reduce |
| Q3 2025 | 754.45K | $216.57M | Reduce |
| Q4 2025 | 752.92K | $188.89M | Hold |
| Q1 2026 | 674.02K | $179.84M | Reduce |
| Q2 2026 | 669.18K | $187.37M | Reduce |
| Q3 2026 | 490.64K | $151.17M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LH and 13F data
LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LH
- VICTORY CAPITAL MANAGEMENT INC 3.92M sh · $1.21B · Q3 2026
- Boston Partners 2.95M sh · $908.74M · Q3 2026
- Allspring Global Investments Holdings, LLC 2.08M sh · $632.21M · Q3 2026
- Select Equity Group, L.P. 1.98M sh · $554.95M · Q2 2026
- THRIVENT FINANCIAL FOR LUTHERANS 705.96K sh · $217.51M · Q3 2026
- Navera Investment Management Ltd. 647.87K sh · $199.60M · Q3 2026
More on COOKE & BIELER LP
FAQ
How long has COOKE & BIELER LP held LH?
COOKE & BIELER LP has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is COOKE & BIELER LP's current position in LH?
As of Q3 2026, COOKE & BIELER LP holds 490.64K shares of LH (LABCORP HOLDINGS INC), valued at $151.17M, representing 2.38% of its reported portfolio and ranking #8.
Has COOKE & BIELER LP been buying or selling LH?
In the latest 13F filing (Q3 2026), COOKE & BIELER LP reduced its position in LH. The position peaked in Q3 2025 at 754.45K shares.
Which other funds hold LH?
Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.